TISSIUM
Mr. Attard joined TISSIUM with an extensive background in corporate finance and Equity Capital Markets having supported a number of mid-cap financing events in Europe and in the U.S, as well as originating and executing mergers and acquisitions among public and private companies.
Mr. Attard joined TISSIUM from ODDO BHF where he spent a decade working in corporate finance. Most recently, he served as Managing Director and Head of Public M&A and ECM. Notably, he supported numerous IPOs as well as capital increases, delistings, takeovers, and others.
TISSIUM
TISSIUM was founded in 2013 to address one of the most persistent medical challenges since the inception of surgical procedures: to reconstruct damaged tissue and restore its natural function.